Publications by authors named "Brian Boylan"

Claim this Profile
T
The chromogenic Bethesda assay and the Nijmegen-Bethesda assay for factor VIII inhibitors in hemophilia A patients: Are they equivalent?
Connie H Miller, Brian Boylan

J Thromb Haemost· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab.
Connie H Miller, Brian Boylan, Amanda B Payne, Jennifer Driggers, Christopher J Bean

Int J Lab Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents.
Brian Boylan, Glenn P Niemeyer, Bonnie Werner, Connie H Miller

Haemophilia· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors.
Amanda B Payne, Connie H Miller, Dorothy Ellingsen, Jennifer Driggers, Brian Boylan

Haemophilia· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening.
Connie H Miller, Anne S Rice, Brian Boylan, Amanda B Payne, Fiona M Kelly

Am J Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
Huiying Zhi, Lubica Rauova, Vincent Hayes, Cunji Gao, Brian Boylan

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.
Cunji Gao, Brian Boylan, Juan Fang, David A Wilcox, Debra K Newman

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia.
Daniel W Bougie, Dhirendra Nayak, Brian Boylan, Peter J Newman, Richard H Aster

Blood· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.
Cunji Gao, Brian Boylan, Dan Bougie, Joan C Gill, Jessica Birenbaum

J Clin Invest· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
Tamam Bakchoul, Brian Boylan, Ulrich J H Sachs, Gregor Bein, Changgeng Ruan

Transfusion· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice.
Reema Goel, Benjamin R Schrank, Shikha Arora, Brian Boylan, Barbara Fleming

Arterioscler Thromb Vasc Biol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
Brian Boylan, Cunji Gao, Vipul Rathore, Joan C Gill, Debra K Newman

Blood· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis.
Reema Goel, Brian Boylan, Lynn Gruman, Peter J Newman, Paula E North

Am J Physiol Gastrointest Liver Physiol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tests of the extension and deadbolt models of integrin activation.
Jieqing Zhu, Brian Boylan, Bing-Hao Luo, Peter J Newman, Timothy A Springer

J Biol Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents.
Brian Boylan, Michael C Berndt, Mark L Kahn, Peter J Newman

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
Brian Boylan, Hong Chen, Vipul Rathore, Cathy Paddock, Michael Salacz

Blood· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of ompR promotes precocious swarming and flhDC expression in Xenorhabdus nematophila.
Dong-jin Kim, Brian Boylan, Nicholas George, Steven Forst

J Bacteriol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the pleiotropic phenotype of an ompR strain of Xenorhabdus nematophila.
Steven Forst, Brian Boylan

Antonie Van Leeuwenhoek· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis